Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Breast Neoplasms × iniparib × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 3 Expanded_access 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Breast Neoplasms 1

Interventions

abemaciclib 2 zenocutuzumab 1 tucatinib 1 selpercatinib 1 ribociclib 1 pegilodecakin 1 iniparib 1 eribulin 1 Proton Pump Inhibitors 1 Hydrocortisone 1 Everolimus 1 Alpelisib 1 Ado-Trastuzumab Emtansine 1 AM0010 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01130259 2013-09-17

An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer

Sanofi

No longer available

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡